Collaboration and Partnership Sample Clauses

Collaboration and Partnership. Alameda County Health Care for the Homeless shall support collaborations by sharing available information on scheduling and services among the Street Health Outreach Teams, and the Health Care for the Homeless mobile unit Additionally, Health Care for the Homeless shall xxxxxx communication and information-sharing with Alameda County Behavioral Health (ACBH) Crisis Response teams, and ACBH Full Service Partnerships focused on homeless. Other possible areas of collaboration include the following:  Meetings to share information, discuss cases, and coordinate referrals. Representatives from Alameda County Behavioral Health (ACBH) will attend on a periodic basis.  Outreach Providers Training and Education Series sponsored by Alameda County Health Care for the Homeless.  Collaboration with the regional Housing Resource Centers (HRCs) and other organizations serving shared clients to connect and re-connect clients to housing services.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Collaboration and Partnership. The University has a long track record of working effectively in partnership with a range of groups. Key to our wider outreach work is our collaboration with the other three Hampshire universities – Southampton Solent University, and the Universities of Portsmouth and Winchester. The Hampshire Universities Widening Participation Group allows for sharing of resources, good practice, training and development. It focuses attention on particular areas of widening participation activity through the work of the following sub-groups (the leadership of which is distributed between the partner institutions): • The BME working group, led by the University of Southampton, has focused on auditing existing activity that supports the recruitment and progression of BME students within each institution, with a view to building on the good practice and contacts we have. This group will continue to develop opportunities to share resources and good practice in this area and to work collaboratively. • The Disability working group connects expertise in outreach and disability support across the universities in order to better inform and support schools and colleges. • The WeCare partnership, comprised of representatives from the universities, local colleges and local authorities, has worked for a number of years to provide information and support for care leavers and their supporters throughout Hampshire. We shall continue to be an active contributor to the Hampshire Universities Widening Participation Group in 2014/15 and beyond, sharing resources, models of working and access to training and development opportunities with our partners. In addition to this, the University will continue to work closely with Southampton Solent University, collaboratively leading and managing the Southampton Junior University Programme. This provides additional support for Southampton secondary school students with regard to progression, retention and attainment. In addition to our Learn with US and Access to Southampton activity, we work in partnership with a number of schools, colleges and other groups including organisations such as Headstart and the Smallpeice Trust. These relationships add value to our outreach programme and provide aspiration-raising and learning opportunities for potential students. During the period leading up to that covered by this Access Agreement, we anticipate developing even deeper and more formal links with a number of our partner secondary schools. In 2013-14 we ...
Sample 1
Collaboration and Partnership. The project will maximize the collaboration with other organizations, partners and initiatives as a feature embedded in all sections as mentioned. The aim is to synergize, avoid duplication, and maximize the return for all the parts collaborating in each area. In some cases, collaboration will intensify and or expand as a continuation of current one (e.g.: AMU or surveillance), but also, new areas will be introduced such as gender and inclusion, the economic case, or support to partners in focus countries not covered by this project.
Sample 1
Collaboration and Partnership. ‌ The HAUPA project was implemented in collaboration with the National Directorate of Water as an extension of the Ministry of Public Works and Housing. There was a limited partnership with the health department at the provincial level but no partnership with the health agency at the community level. A partnership was also developed with technician, such as welders, to address the possibility of interrupted water services due to the lack availability of spare parts. The most important collaboration was with the community to ensure water services were sustained. At the core of the HAUPA project were community mobilization activities.
Sample 1

Related to Collaboration and Partnership

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Formation and Composition The Parties to this agreement will maintain a Joint Administration and Dispute Resolution Committee (JADRC) consisting of five (5) representatives of the employers and five (5) representatives of the Provincial Bargaining Council.

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  • Research Matters By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent’s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

  • Development Efforts Genentech will use commercially reasonable and diligent efforts to develop C2B8, including pursuing preclinical development and clinical development of C2B8 and obtaining Regulatory Approvals therefor in all countries in the Licensed Territory, taking into account the scientific and commercial potential of C2B8, including, without limitation, each of the potential indications in the Field for C2B8. Within ninety (90) days of the Original Effective Date, Genentech agrees to provide IDEC with a written development strategy for C2B8 in the Licensed Territory indicating (i) whether Genentech will develop C2B8 alone or with a partner in Europe, (ii) the identity of its European partner (if any), and (iii) a list of clinical trials which Genentech would conduct for C2B8 approval in Europe assuming adequate quantities of C2B8 are available.

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • Development Agreement As soon as reasonably practicable following the ISO’s selection of a transmission Generator Deactivation Solution, the ISO shall tender to the Developer that proposed the selected transmission Generator Deactivation Solution a draft Development Agreement, with draft appendices completed by the ISO to the extent practicable, for review and completion by the Developer. The draft Development Agreement shall be in the form of the ISO’s Commission-approved Development Agreement for its reliability planning process, which is in Appendix C in Section 31.7 of Attachment Y of the ISO OATT, as amended by the ISO to reflect the Generator Deactivation Process. The ISO and the Developer shall finalize the Development Agreement and appendices as soon as reasonably practicable after the ISO’s tendering of the draft Development Agreement. For purposes of finalizing the Development Agreement, the ISO and Developer shall develop the description and dates for the milestones necessary to develop and construct the selected project by the required in-service date identified in the Generator Deactivation Assessment, including the milestones for obtaining all necessary authorizations. Any milestone that requires action by a Connecting Transmission Owner or Affected System Operator identified pursuant to Attachment P of the ISO OATT to complete must be included as an Advisory Milestone, as that term is defined in the Development Agreement. If the ISO or the Developer determines that negotiations are at an impasse, the ISO may file the Development Agreement in unexecuted form with the Commission on its own, or following the Developer’s request in writing that the agreement be filed unexecuted. If the Development Agreement is executed by both parties, the ISO shall file the agreement with the Commission for its acceptance within ten (10) Business Days after the execution of the Development Agreement by both parties. If the Developer requests that the Development Agreement be filed unexecuted, the ISO shall file the agreement at the Commission within ten (10) Business Days of receipt of the request from the Developer. The ISO will draft, to the extent practicable, the portions of the Development Agreement and appendices that are in dispute and will provide an explanation to the Commission of any matters as to which the parties disagree. The Developer will provide in a separate filing any comments that it has on the unexecuted agreement, including any alternative positions it may have with respect to the disputed provisions. Upon the ISO’s and the Developer’s execution of the Development Agreement or the ISO’s filing of an unexecuted Development Agreement with the Commission, the ISO and the Developer shall perform their respective obligations in accordance with the terms of the Development Agreement that are not in dispute, subject to modification by the Commission. The Connecting Transmission Owner(s) and Affected System Operator(s) that are identified in Attachment P of the ISO OATT in connection with the selected transmission Generator Deactivation Solution shall act in good faith in timely performing their obligations that are required for the Developer to satisfy its obligations under the Development Agreement.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Commercialization Efforts The RECIPIENT shall, including whether through its own efforts or the efforts of a licensee under a License Agreement allowed by the terms of this Attachment, use diligent and commercially reasonable efforts to commercialize at least one Commercial Product or Commercial Service or otherwise bring to practical application the Project Results in accordance with the commercial development plan submitted with the Application and including any changes to such commercial development plan in accordance with Section D3.01. For the avoidance of doubt, partnering or licensing activities shall be considered to be efforts to commercialize.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Time is Money Join Law Insider Premium to draft better contracts faster.